NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2025. All Rights Reserved.
Date: Tuesday, May 6, 2025 11:22

Release 2.26
Suvaxyn MH-One emulsion for injection for pigs (NI)
 
Species: Pigs
Therapeutic indication: Immunological veterinary medical products: For pigs
Active ingredient: Vaccine Antigens
Product:Suvaxyn® MH-One Emulsion for injection for pigs
Product index: Suvaxyn MH-One
Pig - meat: Zero days
Incorporating:
Qualitative and quantitative composition
Each 2 ml dose contains:
Active substance:
Inactivated Mycoplasma hyopneumoniae,
strain P-5722-3
RP* (undiluted) ≥ 1.00
Adjuvants:
Carbopol #941
4.00 mg
Squalane**
3.24 mg
*Relative Potency unit determined by ELISA antigen quantification (in vitro potency test) compared to a reference vaccine.
**As component of MetaStim (that also contains Pluronic L-121 and Polysorbate 80).
Excipients:
Qualitative composition of excipients and other constituents
Quantitative composition if that information is essential for proper administration of the veterinary medicinal product
Thiomersal
0.20 mg
Sodium chloride
Potassium chloride
Sodium phosphate dibasic x12 H2O
Potassium phosphate monobasic
Polysorbate 80
Pluronic L-121
EDTA Tetrasodium 2H2O
Sodium Borate
Sodium Phosphate Dibasic
Water for injections
Brownish-grey emulsion.
Pharmaceutical form
Please refer to the "Qualitative and quantitative composition" section.
Clinical particulars
Target species
Pigs.
Indications for use for each target species
For active immunisation of pigs of a minimum age of 7 days to reduce lung lesions that are caused by Mycoplasma hyopneumoniae.
Onset of immunity: 2 weeks.
Duration of immunity: 6 months after vaccination.
Contraindications
None.
Special warnings
Vaccinate healthy animals only.
Special precautions for use
Special precautions for safe use in the target species:
Avoid stress in the animals around the time of vaccination.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
This veterinary medicinal product contains animal oil. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Adverse events
Pigs:
Very common
(>1 animal / 10 animals treated):
Injection site swelling1
Shivering2
Piloerection2
Depression2, Elevated temperature2/3
Uncommon
(1 to 10 animals / 1,000 animals treated):
Anaphylactic-type reaction
Neurological signs
1May reach 0.3 cm in diameter (palpable, but not visible) and last for up to 2 days.
2Within 4 hours after vaccination and spontaneously resolving within 24 hours without treatment.
3Body temperature increase up to 1.9°C.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
Pregnancy and lactation:
Do not use in pregnant or lactating animals.
Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Administration routes and dosage
One dose (2 ml) per animal should be administered intramuscularly in the neck to pigs from the age of 7 days onwards.
Shake vaccine well before administration and intermittently during the process of vaccination.
It is good practice to allow the vaccine to warm to body temperature in the hand or pocket before administration, to avoid the discomfort of injection of a cold liquid.
Symptoms of overdose (and where applicable, emergency procedures and antidotes)
After administration of a two-fold overdose by the recommended route to 3 weeks-old pigs, no other symptoms than those described under section “Adverse events” can be observed. However, the duration may be prolonged (body temperature increases up to 2 days and local tissue reactions up to 3 days) and the area of local tissue reactions may reach 1.0 cm in diameter. Administration of an overdose of the vaccine has not been investigated in 1 week-old piglets.
Special restrictions for use and special conditions for use, including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products in order to limit the risk of development of resistance
Not applicable
Withdrawal periods
Zero days.
Pharmacological particulars
Immunological information
ATCvet code: QI09AB13
To stimulate active immunity against Mycoplasma hyopneumoniae.
Post-vaccination serum antibody levels are not related to the degree of protection afforded by vaccination.
Pharmaceutical particulars
Major incompatibilities
Do not mix with any other veterinary medicinal product.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
Shelf life after first opening the immediate packaging: use immediately.
Special precautions for storage
Store and transport refrigerated (2 °C – 8 °C).
Do not freeze.
Store in the original container.
Protect from light.
Nature and composition of immediate packaging
Container: HDPE bottle.
Filling volume:125 doses (250 ml), 50 doses (100 ml), 10 doses (20 ml) of vaccine.
Closure: butyl rubber stopper with aluminium cap.
Packaging: carton box containing 1 or 10 bottles of 10, 50 or 125 doses.
Not all pack sizes may be marketed.
Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products
Medicines should not be disposed of via wastewater or household waste.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned.
Marketing Authorisation Holder (if different from distributor)
Zoetis UK Limited
Marketing Authorisation Number
Vm 42058/3023
Significant changes
Date of the first authorisation or date of renewal
24 October 2008
Date of revision of the text
December 2023
Any other information
Classification of veterinary medicinal products
Veterinary medicinal product subject to prescription.
Detailed information on this veterinary medicinal product is available in the Union Product Database (https://medicines.health.europa.eu/veterinary).
Legal category
Legal category: POM-V
GTIN
GTIN description:50 doses (100 ml):
GTIN:08714015020220